The Valley Desk

NCT04579757 · Interventional trial

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Anaplastic Thyroid Cancer, Colorectal Cancer, Gastric Cancer, Metastatic Solid Tumor, Neuroendocrine Tumors, Small Cell Lung Cancer, Soft Tissue Sarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov